Apart from surgical approaches, the treatment of cancer remains largely underpinned by radiotherapy and pharmacological agents that cause damage to cellular DNA, which ultimately causes cancer cell death. DNA polymerases, which are involved in the repair of cellular DNA damage, are therefore potential targets for inhibitors for improving the efficacy of cancer therapy. They can be divided, according to their main function, into two groups, namely replicative and nonreplicative enzymes. At least 15 different DNA polymerases, including their homologs, have been discovered to date, which vary considerably in processivity and fidelity. Many of the nonreplicative (specialized) DNA polymerases replicate DNA in an error-prone fashion, and they have been shown to participate in multiple DNA damage repair and tolerance pathways, which are often aberrant in cancer cells. Alterations in DNA repair pathways involving DNA polymerases have been linked with cancer survival and with treatment response to radiotherapy or to classes of cytotoxic drugs routinely used for cancer treatment, particularly cisplatin, oxaliplatin, etoposide, and bleomycin. Indeed, there are extensive preclinical data to suggest that DNA polymerase inhibition may prove to be a useful approach for increasing the effectiveness of therapies in patients with cancer. Furthermore, specialized DNA polymerases warrant examination of their potential use as clinical biomarkers to select for particular cancer therapies, to individualize treatment for patients. Antioxid. Redox Signal. 00, 000–000.
AbdulovicAL, Jinks-RobertsonS. The in vivo characterization of translesion synthesis across UV-induced lesions in Saccharomyces cerevisiae: insights into Pol zeta- and Pol eta-dependent frameshift mutagenesis. Genetics, 172:1487–1498. 2006.
2.
AcharyaN, JohnsonRE, PrakashS, PrakashL. Complex formation with Rev1 enhances the proficiency of Saccharomyces cerevisiae DNA polymerase zeta for mismatch extension and for extension opposite from DNA lesions. Mol Cell Biol, 26:9555–9563. 2006.
3.
AcharyaN, YoonJH, GaliH, UnkI, HaracskaL, JohnsonRE, HurwitzJ, PrakashL, PrakashS. Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase eta in translesion DNA synthesis. Proc Natl Acad Sci U S A, 105:17724–17729. 2008.
4.
AdachiM, IjichiK, HasegawaY, OgawaT, NakamuraH, YasuiY, FukushimaM, IshizakiK. Hypersensitivity to cisplatin after hRev3 mRNA knockdown in head and neck squamous cell carcinoma cells. Mol Med Report, 1:695–698. 2008.
5.
AlbertellaMR, GreenCM, LehmannAR, O'ConnorMJ. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res, 65:9799–9806. 2005.
6.
AlbertellaMR, LauA, O'ConnorMJ. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst), 4:583–593. 2005.
7.
AllinsonSL, DianovaII, DianovGL. DNA polymerase beta is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts. EMBO J, 20:6919–6926. 2001.
8.
AltA, LammensK, ChiocchiniC, LammensA, PieckJC, KuchD, HopfnerKP, CarellT. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Science, 318:967–970. 2007.
9.
AndersenPL, XuF, XiaoW. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res, 18:162–173. 2008.
10.
AndreassenPR, HoGP, D'AndreaAD. DNA damage responses and their many interactions with the replication fork. Carcinogenesis, 27:883–892. 2006.
11.
AoufouchiS, FlatterE, DahanA, FailiA, BertocciB, StorckS, DelbosF, CoceaL, GuptaN, WeillJC, ReynaudCA. Two novel human and mouse DNA polymerases of the polX family. Nucleic Acids Res, 28:3684–3693. 2000.
12.
AranaME, SekiM, WoodRD, RogozinIB, KunkelTA. Low-fidelity DNA synthesis by human DNA polymerase theta. Nucleic Acids Res, 36:3847–3856. 2008.
13.
AsagoshiK, LiuY, MasaokaA, LanL, PrasadR, HortonJK, BrownAR, WangXH, BdourHM, SobolRW, TaylorJS, YasuiA, WilsonSH. DNA polymerase beta-dependent long patch base excision repair in living cells. DNA Repair (Amst), 9:109–119. 2010.
14.
BakerTA, BellSP. Polymerases and the replisome: machines within machines. Cell, 92:295–305. 1998.
15.
BassettE, VaismanA, HavenerJM, MasutaniC, HanaokaF, ChaneySG. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro. Biochemistry, 42:14197–14206. 2003.
16.
BavouxC, LeopoldinoAM, BergoglioV, OWJ, OgiT, BiethA, JuddeJG, PenaSD, PouponMF, HelledayT, TagawaM, MachadoC, HoffmannJS, CazauxC. Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis. Cancer Res, 65:325–330. 2005.
17.
BeardWA, ShockDD, BatraVK, PedersenLC, WilsonSH. DNA polymerase beta substrate specificity: side chain modulation of the “A-rule”J Biol Chem, 284:31680–31689. 2009.
18.
BeardWA, ShockDD, YangXP, DeLauderSF, WilsonSH. Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity. J Biol Chem, 277:8235–8242. 2002.
19.
BeardWA, WilsonSH. Purification and domain-mapping of mammalian DNA polymerase beta. Methods Enzymol, 262:98–107. 1995.
20.
BeardWA, WilsonSH. Structure and mechanism of DNA polymerase beta. Chem Rev, 106:361–382. 2006.
21.
BebenekK, Garcia-DiazM, ZhouRZ, PovirkLF, KunkelTA. Loop 1 modulates the fidelity of DNA polymerase lambda. Nucleic Acids Res, 38:5419–5431. 2010.
22.
BelousovaEA, MagaG, FanY, KubarevaEA, RomanovaEA, LebedevaNA, OretskayaTS, LavrikOI. DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structures. Biochemistry, 49:4695–4704. 2010.
23.
BennettSE, SungJS, MosbaughDW. Fidelity of uracil-initiated base excision DNA repair in DNA polymerase beta-proficient and -deficient mouse embryonic fibroblast cell extracts. J Biol Chem, 276:42588–42600. 2001.
24.
BergoglioV, FerrariE, HubscherU, CazauxC, HoffmannJS. DNA polymerase beta can incorporate ribonucleotides during DNA synthesis of undamaged and CPD-damaged DNA. J Mol Biol, 331:1017–1023. 2003.
25.
BertocciB, De SmetA, BerekC, WeillJC, ReynaudCA. Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity, 19:203–211. 2003.
26.
BertocciB, De SmetA, WeillJC, ReynaudCA. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity, 25:31–41. 2006.
27.
BienkoM, GreenCM, SabbionedaS, CrosettoN, MaticI, HibbertRG, BegovicT, NiimiA, MannM, LehmannAR, DikicI. Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol Cell, 37:396–407. 2010.
28.
BiertumpfelC, ZhaoY, KondoY, Ramon-MaiquesS, GregoryM, LeeJY, MasutaniC, LehmannAR, HanaokaF, YangW. Structure and mechanism of human DNA polymerase eta. Nature, 465:1044–1048. 2010.
29.
BlancaG, VillaniG, ShevelevI, RamadanK, SpadariS, HubscherU, MagaG. Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. Biochemistry, 43:11605–11615. 2004.
30.
BoudsocqF, BenaimP, CanitrotY, KnibiehlerM, AusseilF, CappJP, BiethA, LongC, DavidB, ShevelevI, Frierich-HeineckenE, HubscherU, AmalricF, MassiotG, HoffmannJS, CazauxC. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta. Mol Pharmacol, 67:1485–1492. 2005.
31.
BraithwaiteEK, KedarPS, StumpoDJ, BertocciB, FreedmanJH, SamsonLD, WilsonSH. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts. PLoS One, 5:e12229. 2010.
32.
BranzeiD, SekiM, EnomotoT. Rad18/Rad5/Mms2-mediated polyubiquitination of PCNA is implicated in replication completion during replication stress. Genes Cells, 9:1031–1042. 2004.
33.
BriebaLG. Template dependent human DNA polymerases. Curr Top Med Chem, 8:1312–1326. 2008.
34.
BrondelloJM, PillaireMJ, RodriguezC, GourraudPA, SelvesJ, CazauxC, PietteJ. Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene, 27:6093–6101. 2008.
35.
BroughtonBC, CordonnierA, KleijerWJ, JaspersNG, FawcettH, RaamsA, GarritsenVH, StaryA, AvrilMF, BoudsocqF, MasutaniC, HanaokaF, FuchsRP, SarasinA, LehmannAR. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci U S A, 99:815–820. 2002.
36.
BrownJA, PackLR, SanmanLE, SuoZ. Efficiency and fidelity of human DNA polymerases lambda and beta during gap-filling DNA synthesis. DNA Repair (Amst), 10:24–33. 2011.
37.
BrownJA, PackLR, SherrerSM, KshetryAK, NewmisterSA, FowlerJD, TaylorJS, SuoZ. Identification of critical residues for the tight binding of both correct and incorrect nucleotides to human DNA polymerase lambda. J Mol Biol, 403:505–515. 2010.
38.
BrownS, NiimiA, LehmannAR. Ubiquitination and deubiquitination of PCNA in response to stalling of the replication fork. Cell Cycle, 8:689–692. 2009.
39.
BryantHE, SchultzN, ThomasHD, ParkerKM, FlowerD, LopezE, KyleS, MeuthM, CurtinNJ, HelledayT. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434:913–917. 2005.
BurschowskyD, RudolfF, RabutG, HerrmannT, PeterM, WiderG. Structural analysis of the conserved ubiquitin-binding motifs (UBMs) of the translesion polymerase iota in complex with ubiquitin. J Biol Chem, 286:1364–1373. 2011.
42.
CabelofDC, GuoZ, RaffoulJJ, SobolRW, WilsonSH, RichardsonA, HeydariAR. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. Cancer Res, 63:5799–5807. 2003.
43.
CabelofDC, IkenoY, NyskaA, BusuttilRA, AnyangweN, VijgJ, MatherlyLH, TuckerJD, WilsonSH, RichardsonA, HeydariAR. Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate. Cancer Res, 66:7460–7465. 2006.
44.
CanitrotY, CazauxC, FrechetM, BouayadiK, LescaC, SallesB, HoffmannJS. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci U S A, 95:12586–12590. 1998.
45.
CanitrotY, FrechetM, ServantL, CazauxC, HoffmannJS. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J, 13:1107–1111. 1999.
46.
CanitrotY, HoffmannJS, CalsouP, HayakawaH, SallesB, CazauxC. Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. FASEB J, 14:1765–1774. 2000.
47.
CappJP, BoudsocqF, BergoglioV, TroucheD, CazauxC, BlancoL, HoffmannJS, CanitrotY. The R438W polymorphism of human DNA polymerase lambda triggers cellular sensitivity to camptothecin by compromising the homologous recombination repair pathway. Carcinogenesis, 31:1742–1747. 2010.
48.
CappJP, BoudsocqF, BertrandP, Laroche-ClaryA, PourquierP, LopezBS, CazauxC, HoffmannJS, CanitrotY. The DNA polymerase lambda is required for the repair of non-compatible DNA double strand breaks by NHEJ in mammalian cells. Nucleic Acids Res, 34:2998–3007. 2006.
49.
CappJP, BoudsocqF, BesnardAG, LopezBS, CazauxC, HoffmannJS, CanitrotY. Involvement of DNA polymerase mu in the repair of a specific subset of DNA double-strand breaks in mammalian cells. Nucleic Acids Res, 35:3551–3560. 2007.
50.
CeppiP, NovelloS, CambieriA, LongoM, MonicaV, Lo IaconoM, Giaj-LevraM, SaviozziS, VolanteM, PapottiM, ScagliottiG. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res, 15:1039–1045. 2009.
51.
ChanK, HoulbrookS, ZhangQM, HarrisonM, HicksonID, DianovGL. Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis, 22:183–188. 2007.
52.
ChanSH, YuAM, McVeyM. Dual roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila. PLoS Genet, 6:e1001005. 2010.
53.
ChaneySG, CampbellSL, BassettE, WuY. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol, 53:3–11. 2005.
54.
ChayotR, DanckaertA, MontagneB, RicchettiM. Lack of DNA polymerase mu affects the kinetics of DNA double-strand break repair and impacts on cellular senescence. DNA Repair (Amst), 9:1187–1199. 2010.
55.
ChenJ, BozzaW, ZhuangZ. Ubiquitination of PCNA and its essential role in eukaryotic translesion synthesis. Cell Biochem Biophys, 60:47–60. 2011.
56.
ChenKH, YakesFM, SrivastavaDK, SinghalRK, SobolRW, HortonJK, Van HoutenB, WilsonSH. Up-regulation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines. Nucleic Acids Res, 26:2001–2007. 1998.
57.
ChenYW, CleaverJE, HanaokaF, ChangCF, ChouKM. A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res, 4:257–265. 2006.
58.
ChoiJY, ChowdhuryG, ZangH, AngelKC, VuCC, PetersonLA, GuengerichFP. Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases. J Biol Chem, 281:38244–38256. 2006.
59.
ChoiJY, LimS, EoffRL, GuengerichFP. Kinetic analysis of base-pairing preference for nucleotide incorporation opposite template pyrimidines by human DNA polymerase iota. J Mol Biol, 389:264–274. 2009.
60.
ChoiJY, ZangH, AngelKC, KozekovID, GoodenoughAK, RizzoCJ, GuengerichFP. Translesion synthesis across 1,N2-ethenoguanine by human DNA polymerases. Chem Res Toxicol, 19:879–886. 2006.
61.
ClairmontCA, SweasyJB. The Pol beta-14 dominant negative rat DNA polymerase beta mutator mutant commits errors during the gap-filling step of base excision repair in Saccharomyces cerevisiae. J Bacteriol, 180:2292–2297. 1998.
62.
CovoS, BlancoL, LivnehZ. Lesion bypass by human DNA polymerase mu reveals a template-dependent, sequence-independent nucleotidyl transferase activity. J Biol Chem, 279:859–865. 2004.
63.
DaubeSS, AradG, LivnehZ. Translesion replication by DNA polymerase beta is modulated by sequence context and stimulated by fork-like flap structures in DNA. Biochemistry, 39:397–405. 2000.
64.
DeRoseEF, ClarksonMW, GilmoreSA, GalbanCJ, TripathyA, HavenerJM, MuellerGA, RamsdenDA, LondonRE, LeeAL. Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining. Biochemistry, 46:12100–12110. 2007.
65.
Di LuccaJ, GuedjM, LacapereJJ, FargnoliMC, BourillonA, DieudeP, DupinN, WolkensteinP, AegerterP, SaiagP, DescampsV, LebbeC, Basset-SeguinN, PerisK, GrandchampB, SoufirN. Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. Eur J Cancer, 45:3228–3236. 2009.
66.
DianovGL, ParsonsJL. Co-ordination of DNA single strand break repair. DNA Repair (Amst), 6:454–460. 2007.
67.
DianovaII, SleethKM, AllinsonSL, ParsonsJL, BreslinC, CaldecottKW, DianovGL. XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. Nucleic Acids Res, 32:2550–2555. 2004.
68.
DiazM, WatsonNB, TurkingtonG, VerkoczyLK, KlinmanNR, McGregorWG. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Mol Cancer Res, 1:836–847. 2003.
69.
DolesJ, OliverTG, CameronER, HsuG, JacksT, WalkerGC, HemannMT. Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci U S A, 107:20786–20791. 2010.
70.
DoublieS, SawayaMR, EllenbergerT. An open and closed case for all polymerases. Structure, 7:R31–R35. 1999.
71.
DumstorfCA, ClarkAB, LinQ, KisslingGE, YuanT, KucherlapatiR, McGregorWG, KunkelTA. Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc Natl Acad Sci U S A, 103:18083–18088. 2006.
72.
DyrkheevaNS, LomzovAA, PyshnyiDV, KhodyrevaSN, LavrikOI. Efficiency of exonucleolytic action of apurinic/apyrimidinic endonuclease 1 towards matched and mismatched dNMP at the 3′ terminus of different oligomeric DNA structures correlates with thermal stability of DNA duplexes. Biochim Biophys Acta, 1764:699–706. 2006.
73.
EfratiE, ToccoG, EritjaR, WilsonSH, GoodmanMF. Abasic translesion synthesis by DNA polymerase beta violates the “A-rule”. Novel types of nucleotide incorporation by human DNA polymerase beta at an abasic lesion in different sequence contexts. J Biol Chem, 272:2559–2569. 1997.
74.
EmiM, FujiwaraY, NakajimaT, TsuchiyaE, TsudaH, HirohashiS, MaedaY, TsurutaK, MiyakiM, NakamuraY. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res, 52:5368–5372. 1992.
75.
EspositoG, GodindaggerI, KleinU, YaspoML, CumanoA, RajewskyK. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr Biol, 10:1221–1224. 2000.
76.
FarmerH, McCabeN, LordCJ, TuttAN, JohnsonDA, RichardsonTB, SantarosaM, DillonKJ, HicksonI, KnightsC, MartinNM, JacksonSP, SmithGC, AshworthA. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434:917–921. 2005.
77.
FlanaganAM, RaffertyG, O'NeillA, RynneL, KellyJ, McCannJ, CartyMP. The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin. Int J Mol Med, 19:589–596. 2007.
78.
FortiniP, DogliottiE. Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. DNA Repair (Amst), 6:398–409. 2007.
79.
FrankEG, WoodgateR. Increased catalytic activity and altered fidelity of human DNA polymerase iota in the presence of manganese. J Biol Chem, 282:24689–24696. 2007.
80.
FrechetM, CanitrotY, BiethA, DogliottiE, CazauxC, HoffmannJS. Deregulated DNA polymerase beta strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities. Oncogene, 21:2320–2327. 2002.
81.
FriedbergEC. Suffering in silence: the tolerance of DNA damage. Nat Rev Mol Cell Biol, 6:943–953. 2005.
82.
FrommeJC, BanerjeeA, VerdineGL. DNA glycosylase recognition and catalysis. Curr Opin Struct Biol, 14:43–49. 2004.
83.
FuY, ZhuY, ZhangK, YeungM, DurocherD, XiaoW. Rad6-Rad18 mediates a eukaryotic SOS response by ubiquitinating the 9-1-1 checkpoint clamp. Cell, 133:601–611. 2008.
84.
GaoZ, MaloneyDJ, DedkovaLM, HechtSM. Inhibitors of DNA polymerase beta: activity and mechanism. Bioorg Med Chem, 16:4331–4340. 2008.
85.
Garcia-DiazM, BebenekK, KrahnJM, KunkelTA, PedersenLC. A closed conformation for the Pol lambda catalytic cycle. Nat Struct Mol Biol, 12:97–98. 2005.
86.
Garcia-DiazM, DominguezO, Lopez-FernandezLA, de LeraLT, SanigerML, RuizJF, ParragaM, Garcia-OrtizMJ, KirchhoffT, del MazoJ, BernadA, BlancoL. DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis. J Mol Biol, 301:851–867. 2000.
87.
GlickE, WhiteLM, ElliottNA, BergD, KiviatNB, LoebLA. Mutations in DNA polymerase eta are not detected in squamous cell carcinoma of the skin. Int J Cancer, 119:2225–2227. 2006.
88.
GoellnerEM, SvilarD, AlmeidaKH, SobolRW. Targeting DNA polymerase ss for therapeutic intervention. Curr Mol Pharmacol, 5:68–87. 2012.
89.
GoffJP, ShieldsDS, SekiM, ChoiS, EpperlyMW, DixonT, WangH, BakkenistCJ, DertingerSD, TorousDK, WittschiebenJ, WoodRD, GreenbergerJS. Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiat Res, 172:165–174. 2009.
90.
GoodheadDT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol, 65:7–17. 1994.
91.
GoodmanMF. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem, 71:17–50. 2002.
GuH, MarthJD, OrbanPC, MossmannH, RajewskyK. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science, 265:103–106. 1994.
94.
GuerangerQ, StaryA, AoufouchiS, FailiA, SarasinA, ReynaudCA, WeillJC. Role of DNA polymerases eta, iota and zeta in UV resistance and UV-induced mutagenesis in a human cell line. DNA Repair (Amst), 7:1551–1562. 2008.
95.
GuoC, Kosarek-StancelJN, TangTS, FriedbergEC. Y-family DNA polymerases in mammalian cells. Cell Mol Life Sci, 66:2363–2381. 2009.
96.
HallMD, OkabeM, ShenDW, LiangXJ, GottesmanMM. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol, 48:495–535. 2008.
97.
HaraK, HashimotoH, MurakumoY, KobayashiS, KogameT, UnzaiS, AkashiS, TakedaS, ShimizuT, SatoM. Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1. J Biol Chem, 285:12299–12307. 2010.
98.
HaracskaL, AcharyaN, UnkI, JohnsonRE, HurwitzJ, PrakashL, PrakashS. A single domain in human DNA polymerase iota mediates interaction with PCNA: implications for translesion DNA synthesis. Mol Cell Biol, 25:1183–1190. 2005.
99.
HaracskaL, PrakashL, PrakashS. Role of human DNA polymerase kappa as an extender in translesion synthesis. Proc Natl Acad Sci U S A, 99:16000–16005. 2002.
100.
HaracskaL, Torres-RamosCA, JohnsonRE, PrakashS, PrakashL. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol Cell Biol, 24:4267–4274. 2004.
101.
HavenerJM, Nick McElhinnySA, BassettE, GaugerM, RamsdenDA, ChaneySG. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu. Biochemistry, 42:1777–1788. 2003.
102.
HelledayT, PetermannE, LundinC, HodgsonB, SharmaRA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer, 8:193–204. 2008.
103.
HibbertRG, HuangA, BoelensR, SixmaTK. E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation by E2 enzyme Rad6. Proc Natl Acad Sci U S A, 108:5590–5595. 2011.
104.
HigginsGS, HarrisAL, PrevoR, HelledayT, McKennaWG, BuffaFM. Overexpression of POLQ confers a poor prognosis in early breast cancer patients. Oncotarget, 1:175–184. 2010.
105.
HigginsGS, PrevoR, LeeYF, HelledayT, MuschelRJ, TaylorS, YoshimuraM, HicksonID, BernhardEJ, McKennaWG. A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res, 70:2984–2993. 2010.
106.
HiroseF, HottaY, YamaguchiM, MatsukageA. Difference in the expression level of DNA polymerase beta among mouse tissues: high expression in the pachytene spermatocyte. Exp Cell Res, 181:169–180. 1989.
107.
HoggM, SekiM, WoodRD, DoublieS, WallaceSS. Lesion bypass activity of DNA polymerase theta (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts. J Mol Biol, 405:642–652. 2011.
108.
HortonJK, BakerA, BergBJ, SobolRW, WilsonSH. Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage. DNA Repair (Amst), 1:317–333. 2002.
109.
HubscherU, MagaG, SpadariS. Eukaryotic DNA polymerases. Annu Rev Biochem, 71:133–163. 2002.
IshimaruC, KuriyamaI, ShimazakiN, KoiwaiO, SakaguchiK, KatoI, YoshidaH, MizushinaY. Cholesterol hemisuccinate: a selective inhibitor of family X DNA polymerases. Biochem Biophys Res Commun, 354:619–625. 2007.
112.
ItoA, KoshikawaN, MochizukiS, OmuraK, TakenagaK. Hypoxia-inducible factor-1 mediates the expression of DNA polymerase iota in human tumor cells. Biochem Biophys Res Commun, 351:306–311. 2006.
113.
JaiswalAS, BanerjeeS, AnejaR, SarkarFH, OstrovDA, NarayanS. DNA polymerase beta as a novel target for chemotherapeutic intervention of colorectal cancer. PLoS One, 6:e16691. 2011.
114.
JohanssonE, MacneillSA. The eukaryotic replicative DNA polymerases take shape. Trends Biochem Sci, 35:339–347. 2010.
115.
JohnsonKA. The kinetic and chemical mechanism of high-fidelity DNA polymerases. Biochim Biophys Acta, 1804:1041–1048. 2010.
116.
JohnsonRE, HaracskaL, PrakashL, PrakashS. Role of hoogsteen edge hydrogen bonding at template purines in nucleotide incorporation by human DNA polymerase iota. Mol Cell Biol, 26:6435–6441. 2006.
117.
JohnsonRE, KondratickCM, PrakashS, PrakashL. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science, 285:263–265. 1999.
118.
JohnsonRE, WashingtonMT, HaracskaL, PrakashS, PrakashL. Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. Nature, 406:1015–1019. 2000.
119.
JohnsonRE, YuSL, PrakashS, PrakashL. A role for yeast and human translesion synthesis DNA polymerases in promoting replication through 3-methyl adenine. Mol Cell Biol, 27:7198–7205. 2007.
120.
KaiM, WangTS. Checkpoint responses to replication stalling: inducing tolerance and preventing mutagenesis. Mutat Res, 532:59–73. 2003.
121.
KakarS, WatsonNB, McGregorWG. RAD18 signals DNA polymerase IOTA to stalled replication forks in cells entering S-phase with DNA damage. Adv Exp Med Biol, 614:137–143. 2008.
122.
KamisukiS, IshimaruC, OnodaK, KuriyamaI, IdaN, SugawaraF, YoshidaH, MizushinaY. Nodulisporol and Nodulisporone, novel specific inhibitors of human DNA polymerase lambda from a fungus, Nodulisporium sp. Bioorg Med Chem, 15:3109–3114. 2007.
123.
KannoucheP, BroughtonBC, VolkerM, HanaokaF, MullendersLH, LehmannAR. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev, 15:158–172. 2001.
124.
KannoucheP, Fernandez de HenestrosaAR, CoullB, VidalAE, GrayC, ZichaD, WoodgateR, LehmannAR. Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J, 22:1223–1233. 2003.
125.
KannoucheP, StaryA. Xeroderma pigmentosum variant and error-prone DNA polymerases. Biochimie, 85:1123–1132. 2003.
126.
KawamotoT, ArakiK, SonodaE, YamashitaYM, HaradaK, KikuchiK, MasutaniC, HanaokaF, NozakiK, HashimotoN, TakedaS. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol Cell, 20:793–799. 2005.
127.
KawamuraK, BaharR, SeimiyaM, ChiyoM, WadaA, OkadaS, HatanoM, TokuhisaT, KimuraH, WatanabeS, HondaI, SakiyamaS, TagawaM, O-WangJ. DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers. Int J Cancer, 109:9–16. 2004.
128.
KimuraT, NishidaM, KuramochiK, SugawaraF, YoshidaH, MizushinaY. Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp. Bioorg Med Chem, 16:4594–4599. 2008.
129.
KimuraT, TakeuchiT, Kumamoto-YonezawaY, OhashiE, OhmoriH, MasutaniC, HanaokaF, SugawaraF, YoshidaH, MizushinaY. Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases. Bioorg Med Chem, 17:1811–1816. 2009.
130.
KingNM, Nikolaishvili-FeinbergN, BryantMF, LucheDD, HeffernanTP, SimpsonDA, HanaokaF, KaufmannWK, Cordeiro-StoneM. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts. DNA Repair (Amst), 4:714–724. 2005.
131.
KlunglandA, LindahlT. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1)EMBO J, 16:3341–3348. 1997.
132.
KobayashiS, ValentineMR, PhamP, O'DonnellM, GoodmanMF. Fidelity of Escherichia coli DNA polymerase IV. Preferential generation of small deletion mutations by dNTP-stabilized misalignment. J Biol Chem, 277:34198–34207. 2002.
133.
KohzakiM, NishiharaK, HirotaK, SonodaE, YoshimuraM, EkinoS, ButlerJE, WatanabeM, HalazonetisTD, TakedaS. DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. J Cell Biol, 189:1117–1127. 2010.
134.
KunkelTA. Considering the cancer consequences of altered DNA polymerase function. Cancer Cell, 3:105–110. 2003.
135.
KunkelTA, BebenekK. DNA replication fidelity. Annu Rev Biochem, 69:497–529. 2000.
136.
KunkelTA, BurgersPM. Dividing the workload at a eukaryotic replication fork. Trends Cell Biol, 18:521–527. 2008.
137.
KusumotoR, MasutaniC, ShimmyoS, IwaiS, HanaokaF. DNA binding properties of human DNA polymerase eta: implications for fidelity and polymerase switching of translesion synthesis. Genes Cells, 9:1139–1150. 2004.
138.
LangT, DalalS, ChikovaA, DiMaioD, SweasyJB. The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol Cell Biol, 27:5587–5596. 2007.
139.
LangT, MaitraM, StarcevicD, LiSX, SweasyJB. A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc Natl Acad Sci U S A, 101:6074–6079. 2004.
140.
LangeSS, TakataK, WoodRD. DNA polymerases and cancer. Nat Rev Cancer, 11:96–110. 2011.
141.
LawsonMH, CummingsNM, RasslDM, RussellR, BrentonJD, RintoulRC, MurphyG. Two novel determinants of etoposide resistance in small cell lung cancer. Cancer Res, 71:4877–4887. 2011.
142.
LeeGH, MatsushitaH. Genetic linkage between Pol iota deficiency and increased susceptibility to lung tumors in mice. Cancer Sci, 96:256–259. 2005.
143.
LeeJW, BlancoL, ZhouT, Garcia-DiazM, BebenekK, KunkelTA, WangZ, PovirkLF. Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J Biol Chem, 279:805–811. 2004.
144.
LehmannAR, NiimiA, OgiT, BrownS, SabbionedaS, WingJF, KannouchePL, GreenCM. Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst), 6:891–899. 2007.
145.
LemeeF, BergoglioV, Fernandez-VidalA, Machado-SilvaA, PillaireMJ, BiethA, GentilC, BakerL, MartinAL, LeducC, LamE, MagdeleineE, FilleronT, OumouhouN, KainaB, SekiM, GrimalF, Lacroix-TrikiM, ThompsonA, RocheH, BourdonJC, WoodRD, HoffmannJS, CazauxC. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci U S A, 107:13390–13395. 2010.
146.
LiSS, GaoZ, FengX, JonesSH, HechtSM. Plant sterols as selective DNA polymerase beta lyase inhibitors and potentiators of bleomycin cytotoxicity. Bioorg Med Chem, 12:4253–4258. 2004.
LinX, TrangJ, OkudaT, HowellSB. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin Cancer Res, 12:563–568. 2006.
149.
LindahlT, WoodRD. Quality control by DNA repair. Science, 286:1897–1905. 1999.
150.
LingH, BoudsocqF, WoodgateR, YangW. Crystal structure of a Y-family DNA polymerase in action: a mechanism for error-prone and lesion-bypass replication. Cell, 107:91–102. 2001.
151.
LohSY, MistryP, KellandLR, AbelG, HarrapKR. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes. Br J Cancer, 66:1109–1115. 1992.
152.
LoneS, TownsonSA, UljonSN, JohnsonRE, BrahmaA, NairDT, PrakashS, PrakashL, AggarwalAK. Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass. Mol Cell, 25:601–614. 2007.
153.
LucasD, EscuderoB, LigosJM, SegoviaJC, EstradaJC, TerradosG, BlancoL, SamperE, BernadA. Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient double-strand break repair. PLoS Genet, 5:e1000389. 2009.
154.
MaY, LuH, TippinB, GoodmanMF, ShimazakiN, KoiwaiO, HsiehCL, SchwarzK, LieberMR. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol Cell, 16:701–713. 2004.
155.
MacoskaJA, TrybusTM, SakrWA, WolfMC, BensonPD, PowellIJ, PontesJE. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res, 54:3824–3830. 1994.
156.
MagaG, VillaniG, CrespanE, WimmerU, FerrariE, BertocciB, HubscherU. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature, 447:606–608. 2007.
157.
MahajanKN, Nick McElhinnySA, MitchellBS, RamsdenDA. Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol, 22:5194–5202. 2002.
158.
MahaneyBL, MeekK, Lees-MillerSP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J, 417:639–650. 2009.
159.
MaitraM, GudzelakAJr., LiSX, MatsumotoY, EckertKA, JagerJ, SweasyJB. Threonine 79 is a hinge residue that governs the fidelity of DNA polymerase beta by helping to position the DNA within the active site. J Biol Chem, 277:35550–35560. 2002.
160.
MartomoSA, SaribasakH, YokoiM, HanaokaF, GearhartPJ. Reevaluation of the role of DNA polymerase theta in somatic hypermutation of immunoglobulin genes. DNA Repair (Amst), 7:1603–1608. 2008.
161.
MasutaniC, KusumotoR, IwaiS, HanaokaF. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J, 19:3100–3109. 2000.
162.
MasutaniC, KusumotoR, YamadaA, DohmaeN, YokoiM, YuasaM, ArakiM, IwaiS, TakioK, HanaokaF. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature, 399:700–704. 1999.
163.
MatsukageA, YamaguchiM, UtsumiKR, HayashiY, UedaR, YoshidaMC. Assignment of the gene for human DNA polymerase beta (POLB) to chromosome 8. Jpn J Cancer Res, 77:330–333. 1986.
164.
MatsumotoY, KimK. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science, 269:699–702. 1995.
165.
McCullochSD, KokoskaRJ, ChilkovaO, WelchCM, JohanssonE, BurgersPM, KunkelTA. Enzymatic switching for efficient and accurate translesion DNA replication. Nucleic Acids Res, 32:4665–4675. 2004.
166.
McCullochSD, KokoskaRJ, MasutaniC, IwaiS, HanaokaF, KunkelTA. Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity. Nature, 428:97–100. 2004.
167.
McCullochSD, KunkelTA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res, 18:148–161. 2008.
168.
McCulloughAK, DodsonML, LloydRS. Initiation of base excision repair: glycosylase mechanisms and structures. Annu Rev Biochem, 68:255–285. 1999.
169.
McDonaldJP, TissierA, FrankEG, IwaiS, HanaokaF, WoodgateR. DNA polymerase iota and related rad30-like enzymes. Philos Trans R Soc Lond B Biol Sci, 356:53–60. 2001.
170.
McIlwraithMJ, VaismanA, LiuY, FanningE, WoodgateR, WestSC. Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol Cell, 20:783–792. 2005.
171.
MeijerC, MulderNH, Timmer-BosschaH, SluiterWJ, MeersmaGJ, de VriesEG. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res, 52:6885–6889. 1992.
172.
MellishKJ, KellandLR, HarrapKR. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer, 68:240–250. 1993.
173.
MichelB, GromponeG, FloresMJ, BidnenkoV. Multiple pathways process stalled replication forks. Proc Natl Acad Sci U S A, 101:12783–12788. 2004.
174.
MinkoIG, HarbutMB, KozekovID, KozekovaA, JakobsPM, OlsonSB, MosesRE, HarrisTM, RizzoCJ, LloydRS. Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J Biol Chem, 283:17075–17082. 2008.
175.
MizushinaY, MotoshimaH, YamaguchiY, TakeuchiT, HiranoK, SugawaraF, YoshidaH. 3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain. Mar Drugs, 7:624–639. 2009.
176.
MizushinaY, NakagawaK, ShibataA, AwataY, KuriyamaI, ShimazakiN, KoiwaiO, UchiyamaY, SakaguchiK, MiyazawaT, YoshidaH. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochem Biophys Res Commun, 339:949–955. 2006.
177.
MoonAF, Garcia-DiazM, BatraVK, BeardWA, BebenekK, KunkelTA, WilsonSH, PedersenLC. The X family portrait: structural insights into biological functions of X family polymerases. DNA Repair (Amst), 6:1709–1725. 2007.
178.
MuellerGA, MoonAF, DeroseEF, HavenerJM, RamsdenDA, PedersenLC, LondonRE. A comparison of BRCT domains involved in nonhomologous end-joining: introducing the solution structure of the BRCT domain of polymerase lambda. DNA Repair (Amst), 7:1340–1351. 2008.
179.
MuzziniDM, PlevaniP, BoultonSJ, CassataG, MariniF. Caenorhabditis elegans POLQ-1 and HEL-308 function in two distinct DNA interstrand cross-link repair pathways. DNA Repair (Amst), 7:941–950. 2008.
180.
NaganumaM, NishidaM, KuramochiK, SugawaraF, YoshidaH, MizushinaY. 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Bioorg Med Chem, 16:2939–2944. 2008.
181.
NairDT, JohnsonRE, PrakashS, PrakashL, AggarwalAK. Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing. Nature, 430:377–380. 2004.
182.
NeijenhuisS, BeggAC, VensC. Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent. Radiother Oncol, 76:123–128. 2005.
183.
NeijenhuisS, Verwijs-JanssenM, Kasten-PisulaU, RumpingG, BorgmannK, DikomeyE, BeggAC, VensC. Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta. DNA Repair (Amst), 8:336–346. 2009.
184.
Nick McElhinnySA, RamsdenDA. Polymerase mu is a DNA-directed DNA/RNA polymerase. Mol Cell Biol, 23:2309–2315. 2003.
185.
O-WangJ, KawamuraK, TadaY, OhmoriH, KimuraH, SakiyamaS, TagawaM. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res, 61:5366–5369. 2001.
186.
OchsK, SobolRW, WilsonSH, KainaB. Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. Cancer Res, 59:1544–1551. 1999.
187.
OgiT, KannoucheP, LehmannAR. Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci. J Cell Sci, 118:129–136. 2005.
188.
OgiT, LehmannAR. The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair. Nat Cell Biol, 8:640–642. 2006.
189.
OgiT, LimsirichaikulS, OvermeerRM, VolkerM, TakenakaK, CloneyR, NakazawaY, NiimiA, MikiY, JaspersNG, MullendersLH, YamashitaS, FousteriMI, LehmannAR. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol Cell, 37:714–727. 2010.
190.
OhashiE, BebenekK, MatsudaT, FeaverWJ, GerlachVL, FriedbergEC, OhmoriH, KunkelTA. Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene. J Biol Chem, 275:39678–39684. 2000.
191.
OhashiE, HanafusaT, KameiK, SongI, TomidaJ, HashimotoH, VaziriC, OhmoriH. Identification of a novel REV1-interacting motif necessary for DNA polymerase kappa function. Genes Cells, 14:101–111. 2009.
192.
OhbaT, KometaniT, ShojiF, YanoT, YoshinoI, TaguchiK, KuraokaI, OdaS, MaeharaY. Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Mutat Res, 677:66–71. 2009.
193.
OhkumoT, KondoY, YokoiM, TsukamotoT, YamadaA, SugimotoT, KanaoR, HigashiY, KondohH, TatematsuM, MasutaniC, HanaokaF. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota. Mol Cell Biol, 26:7696–7706. 2006.
194.
PanQ, FangY, XuY, ZhangK, HuX. Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers. Cancer Lett, 217:139–147. 2005.
195.
ParsonsJL, DianovaII, AllinsonSL, DianovGL. DNA polymerase beta promotes recruitment of DNA ligase III alpha-XRCC1 to sites of base excision repair. Biochemistry, 44:10613–10619. 2005.
196.
PascucciB, StuckiM, JonssonZO, DogliottiE, HubscherU. Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon. J Biol Chem, 274:33696–33702. 1999.
197.
PelletierH, SawayaMR, KumarA, WilsonSH, KrautJ. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science, 264:1891–1903. 1994.
198.
PettaTB, NakajimaS, ZlatanouA, DesprasE, Couve-PrivatS, IshchenkoA, SarasinA, YasuiA, KannoucheP. Human DNA polymerase iota protects cells against oxidative stress. EMBO J, 27:2883–2895. 2008.
199.
PillaireMJ, BetousR, ContiC, CzaplickiJ, PaseroP, BensimonA, CazauxC, HoffmannJS. Upregulation of error-prone DNA polymerases beta and kappa slows down fork progression without activating the replication checkpoint. Cell Cycle, 6:471–477. 2007.
200.
PillaireMJ, SelvesJ, GordienK, GourraudPA, GentilC, DanjouxM, DoC, NegreV, BiethA, GuimbaudR, TroucheD, PaseroP, MechaliM, HoffmannJS, CazauxC. A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer. Oncogene, 29:876–887. 2010.
201.
PoltoratskyV, HortonJK, PrasadR, BeardWA, WoodgateR, WilsonSH. Negligible impact of pol iota expression on the alkylation sensitivity of pol beta-deficient mouse fibroblast cells. DNA Repair (Amst), 7:830–833. 2008.
202.
PoltoratskyV, HortonJK, PrasadR, WilsonSH. REV1 mediated mutagenesis in base excision repair deficient mouse fibroblast. DNA Repair (Amst), 4:1182–1188. 2005.
203.
PrakashS, JohnsonRE, PrakashL. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem, 74:317–353. 2005.
204.
Prakasha GowdaAS, PolizziJM, EckertKA, SprattTE. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry, 49:4833–4840. 2010.
205.
PrasadR, BeardWA, StraussPR, WilsonSH. Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J Biol Chem, 273:15263–15270. 1998.
206.
PrasadR, LongleyMJ, ShariefFS, HouEW, CopelandWC, WilsonSH. Human DNA polymerase theta possesses 5′-dRP lyase activity and functions in single-nucleotide base excision repair in vitro. Nucleic Acids Res, 37:1868–1877. 2009.
207.
PrasadR, WidenSG, SinghalRK, WatkinsJ, PrakashL, WilsonSH. Yeast open reading frame YCR14C encodes a DNA beta-polymerase-like enzyme. Nucleic Acids Res, 21:5301–5307. 1993.
208.
PrestonBD, AlbertsonTM, HerrAJ. DNA replication fidelity and cancer. Semin Cancer Biol, 20:281–293. 2010.
209.
RajpalDK, WuX, WangZ. Alteration of ultraviolet-induced mutagenesis in yeast through molecular modulation of the REV3 and REV7 gene expression. Mutat Res, 461:133–143. 2000.
210.
RechkoblitO, ZhangY, GuoD, WangZ, AminS, KrzeminskyJ, LounevaN, GeacintovNE. trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases. J Biol Chem, 277:30488–30494. 2002.
211.
RoettgerMP, FialaKA, SompalliS, DongY, SuoZ. Pre-steady-state kinetic studies of the fidelity of human DNA polymerase mu. Biochemistry, 43:13827–13838. 2004.
212.
RuizJF, JuarezR, Garcia-DiazM, TerradosG, PicherAJ, Gonzalez-BarreraS, Fernandez de HenestrosaAR, BlancoL. Lack of sugar discrimination by human Pol mu requires a single glycine residue. Nucleic Acids Res, 31:4441–4449. 2003.
213.
RuizJF, LucasD, Garcia-PalomeroE, SaezAI, GonzalezMA, PirisMA, BernadA, BlancoL. Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate. Nucleic Acids Res, 32:5861–5873. 2004.
214.
SabbionedaS, MinesingerBK, GiannattasioM, PlevaniP, Muzi-FalconiM, Jinks-RobertsonS. The 9-1-1 checkpoint clamp physically interacts with polzeta and is partially required for spontaneous polzeta-dependent mutagenesis in Saccharomyces cerevisiae. J Biol Chem, 280:38657–38665. 2005.
215.
SandersonRJ, MosbaughDW. Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. J Biol Chem, 273:24822–24831. 1998.
216.
SchmutzV, Janel-BintzR, WagnerJ, BiardD, ShiomiN, FuchsRP, CordonnierAM. Role of the ubiquitin-binding domain of Poleta in Rad18-independent translesion DNA synthesis in human cell extracts. Nucleic Acids Res, 38:6456–6465. 2010.
217.
SekiM, MariniF, WoodRD. POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res, 31:6117–6126. 2003.
218.
SekiM, MasutaniC, YangLW, SchuffertA, IwaiS, BaharI, WoodRD. High-efficiency bypass of DNA damage by human DNA polymerase Q. EMBO J, 23:4484–4494. 2004.
219.
SekiM, WoodRD. DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6–4) photoproduct. DNA Repair (Amst), 7:119–127. 2008.
220.
ServantL, CazauxC, BiethA, IwaiS, HanaokaF, HoffmannJS. A role for DNA polymerase beta in mutagenic UV lesion bypass. J Biol Chem, 277:50046–50053. 2002.
221.
SharmaRA, DianovGL. Targeting base excision repair to improve cancer therapies. Mol Aspects Med, 28:345–374. 2007.
ShimizuT, AzumaT, IshiguroM, KanjoN, YamadaS, OhmoriH. Normal immunoglobulin gene somatic hypermutation in Pol kappa-Pol iota double-deficient mice. Immunol Lett, 98:259–264. 2005.
224.
SilversteinTD, JohnsonRE, JainR, PrakashL, PrakashS, AggarwalAK. Structural basis for the suppression of skin cancers by DNA polymerase eta. Nature, 465:1039–1043. 2010.
225.
SleethKM, RobsonRL, DianovGL. Exchangeability of mammalian DNA ligases between base excision repair pathways. Biochemistry, 43:12924–12930. 2004.
226.
SobolRW, HortonJK, KuhnR, GuH, SinghalRK, PrasadR, RajewskyK, WilsonSH. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature, 379:183–186. 1996.
227.
SobolRW, WatsonDE, NakamuraJ, YakesFM, HouE, HortonJK, LadapoJ, Van HoutenB, SwenbergJA, TindallKR, SamsonLD, WilsonSH. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci U S A, 99:6860–6865. 2002.
228.
SrivastavaDK, HusainI, ArteagaCL, WilsonSH. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis, 20:1049–1054. 1999.
229.
StachelekGC, DalalS, DoniganKA, Campisi HeganD, SweasyJB, GlazerPM. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res, 70:409–417. 2010.
230.
StancelJN, McDanielLD, VelascoS, RichardsonJ, GuoC, FriedbergEC. Polk mutant mice have a spontaneous mutator phenotype. DNA Repair (Amst), 8:1355–1362. 2009.
231.
StarcevicD, DalalS, SweasyJB. Is there a link between DNA polymerase beta and cancer?Cell Cycle, 3:998–1001. 2004.
232.
SteitzTA. DNA polymerases: structural diversity and common mechanisms. J Biol Chem, 274:17395–17398. 1999.
233.
SukhanovaMV, KhodyrevaSN, LebedevaNA, PrasadR, WilsonSH, LavrikOI. Human base excision repair enzymes apurinic/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity. Nucleic Acids Res, 33:1222–1229. 2005.
234.
SweasyJB, LangT, StarcevicD, SunKW, LaiCC, DimaioD, DalalS. Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. Proc Natl Acad Sci U S A, 102:14350–14355. 2005.
235.
TakenakaK, OgiT, OkadaT, SonodaE, GuoC, FriedbergEC, TakedaS. Involvement of vertebrate Polkappa in translesion DNA synthesis across DNA monoalkylation damage. J Biol Chem, 281:2000–2004. 2006.
236.
TaniokaM, MasakiT, OnoR, NaganoT, Otoshi-HondaE, MatsumuraY, TakigawaM, InuiH, MiyachiY, MoriwakiS, NishigoriC. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol, 127:1745–1751. 2007.
237.
TengKY, QiuMZ, LiZH, LuoHY, ZengZL, LuoRZ, ZhangHZ, WangZQ, LiYH, XuRH. DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med, 8:126. 2010.
238.
TerradosG, CappJP, CanitrotY, Garcia-DiazM, BebenekK, KirchhoffT, VillanuevaA, BoudsocqF, BergoglioV, CazauxC, KunkelTA, HoffmannJS, BlancoL. Characterization of a natural mutator variant of human DNA polymerase lambda which promotes chromosomal instability by compromising NHEJ. PLoS One, 4:e7290. 2009.
239.
ThakurM, WernickM, CollinsC, LimoliCL, CrowleyE, CleaverJE. DNA polymerase eta undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosomes Cancer, 32:222–235. 2001.
240.
TrivediRN, AlmeidaKH, FornsaglioJL, SchamusS, SobolRW. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. Cancer Res, 65:6394–6400. 2005.
241.
TrivediRN, WangXH, JelezcovaE, GoellnerEM, TangJB, SobolRW. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol Pharmacol, 74:505–516. 2008.
242.
UchiyamaY, TakeuchiR, KoderaH, SakaguchiK. Distribution and roles of X-family DNA polymerases in eukaryotes. Biochimie, 91:165–170. 2009.
243.
VaismanA, ChaneySG. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta. J Biol Chem, 275:13017–13025. 2000.
244.
VaismanA, MasutaniC, HanaokaF, ChaneySG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. Biochemistry, 39:4575–4580. 2000.
245.
VaismanA, WarrenMW, ChaneySG. The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts. J Biol Chem, 276:18999–19005. 2001.
246.
ValkK, VooderT, KoldeR, ReintamMA, PetzoldC, ViloJ, MetspaluA. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology, 79:283–292. 2010.
247.
van der BoschK, BeckerI, SavelyevaL, BruderleinS, SchlagP, SchwabM. Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes Cancer, 5:91–95. 1992.
248.
VaradiV, BevierM, GrzybowskaE, JohanssonR, EnquistK, HenrikssonR, ButkiewiczD, Pamula-PilatJ, TeczaK, HemminkiK, LennerP, ForstiA. Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat, 129:235–245. 2011.
249.
VensC, Dahmen-MoorenE, Verwijs-JanssenM, BlyweertW, GraversenL, BartelinkH, BeggAC. The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cells. Nucleic Acids Res, 30:2995–3004. 2002.
250.
VermeulenC, BertocciB, BeggAC, VensC. Ionizing radiation sensitivity of DNA polymerase lambda-deficient cells. Radiat Res, 168:683–688. 2007.
251.
WangH, WuW, WangHW, WangS, ChenY, ZhangX, YangJ, ZhaoS, DingHF, LuD. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. Neuro Oncol, 12:679–686. 2010.
252.
WangY, WoodgateR, McManusTP, MeadS, McCormickJJ, MaherVM. Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res, 67:3018–3026. 2007.
253.
WashingtonMT, JohnsonRE, PrakashL, PrakashS. Accuracy of lesion bypass by yeast and human DNA polymerase eta. Proc Natl Acad Sci U S A, 98:8355–8360. 2001.
254.
WashingtonMT, JohnsonRE, PrakashL, PrakashS. Human DINB1-encoded DNA polymerase kappa is a promiscuous extender of mispaired primer termini. Proc Natl Acad Sci U S A, 99:1910–1914. 2002.
255.
WatanabeK, TateishiS, KawasujiM, TsurimotoT, InoueH, YamaizumiM. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J, 23:3886–3896. 2004.
256.
WatersLS, MinesingerBK, WiltroutME, D'SouzaS, WoodruffRV, WalkerGC. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev, 73:134–154. 2009.
257.
WeinfeldM. Complexities of BER. Prog Nucleic Acid Res Mol Biol, 68:125–127. 2001.
258.
WiebauerK, JiricnyJ. Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells. Proc Natl Acad Sci U S A, 87:5842–5845. 1990.
259.
WimmerU, FerrariE, HunzikerP, HubscherU. Control of DNA polymerase lambda stability by phosphorylation and ubiquitination during the cell cycle. EMBO Rep, 9:1027–1033. 2008.
WittschiebenJP, ReshmiSC, GollinSM, WoodRD. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res, 66:134–142. 2006.
262.
YagiY, OgawaraD, IwaiS, HanaokaF, AkiyamaM, MakiH. DNA polymerases eta and kappa are responsible for error-free translesion DNA synthesis activity over a cis-syn thymine dimer in Xenopus laevis oocyte extracts. DNA Repair (Amst), 4:1252–1269. 2005.
263.
YamtichJ, StarcevicD, LauperJ, SmithE, ShiI, RangarajanS, JaegerJ, SweasyJB. Hinge residue I174 is critical for proper dNTP selection by DNA polymerase beta. Biochemistry, 49:2326–2334. 2010.
264.
YamtichJ, SweasyJB. DNA polymerase family X: function, structure, and cellular roles. Biochim Biophys Acta, 1804:1136–1150. 2010.
265.
YangJ, ChenZ, LiuY, HickeyRJ, MalkasLH. Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res, 64:5597–5607. 2004.
266.
YangJ, ParsonsJ, NicolayNH, CaporaliS, HarringtonCF, SinghR, FinchD, D'AtriS, FarmerPB, JohnstonPG, McKennaWG, DianovG, SharmaRA. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene, 29:463–468. 2010.
267.
YasuiM, SuzukiN, LaxmiYR, ShibutaniS. Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa. Biochemistry, 45:12167–12174. 2006.
268.
YoshimuraM, KohzakiM, NakamuraJ, AsagoshiK, SonodaE, HouE, PrasadR, WilsonSH, TanoK, YasuiA, LanL, SekiM, WoodRD, ArakawaH, BuersteddeJM, HocheggerH, OkadaT, HiraokaM, TakedaS. Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Mol Cell, 24:115–125. 2006.
269.
ZahnKE, WallaceSS, DoublieS. DNA polymerases provide a canon of strategies for translesion synthesis past oxidatively generated lesions. Curr Opin Struct Biol, 21:358–369. 2011.
270.
ZhangY, WuX, GuoD, RechkoblitO, TaylorJS, GeacintovNE, WangZ. Lesion bypass activities of human DNA polymerase mu. J Biol Chem, 277:44582–44587. 2002.
271.
ZhangY, WuX, YuanF, XieZ, WangZ. Highly frequent frameshift DNA synthesis by human DNA polymerase mu. Mol Cell Biol, 21:7995–8006. 2001.
272.
ZhangY, YuanF, WuX, RechkoblitO, TaylorJS, GeacintovNE, WangZ. Error-prone lesion bypass by human DNA polymerase eta. Nucleic Acids Res, 28:4717–4724. 2000.
273.
ZhongX, GargP, StithCM, Nick McElhinnySA, KisslingGE, BurgersPM, KunkelTA. The fidelity of DNA synthesis by yeast DNA polymerase zeta alone and with accessory proteins. Nucleic Acids Res, 34:4731–4742. 2006.
274.
ZmudzkaBZ, FornaceA, CollinsJ, WilsonSH. Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells. Nucleic Acids Res, 16:9587–9596. 1988.
